42287-92-3 Usage
Uses
Used in Organic Pigment and Dye Production:
3-(3,5-DINITROPHENYL)PROPIONIC ACID is used as a key intermediate in the synthesis of organic pigments and dyes, contributing to the development of colorants with specific properties for various applications.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 3-(3,5-DINITROPHENYL)PROPIONIC ACID serves as an intermediate in the production of certain drugs, playing a crucial role in the synthesis process to achieve desired medicinal compounds.
Used in Analytical Chemistry:
3-(3,5-DINITROPHENYL)PROPIONIC ACID is utilized as a reagent in the detection and analysis of amino acids and proteins, aiding researchers and scientists in their studies and experiments.
Safety Considerations:
Given its potentially hazardous nature, 3-(3,5-DINITROPHENYL)PROPIONIC ACID should be handled with care. It is toxic if ingested, inhaled, or comes into contact with the skin, necessitating proper safety measures during its use and storage.
Check Digit Verification of cas no
The CAS Registry Mumber 42287-92-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,2,8 and 7 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 42287-92:
(7*4)+(6*2)+(5*2)+(4*8)+(3*7)+(2*9)+(1*2)=123
123 % 10 = 3
So 42287-92-3 is a valid CAS Registry Number.
42287-92-3Relevant academic research and scientific papers
SUBSTITUTED 1,2,4-OXADIAZOLE, ITS APPLICATION AND A PHARMACEUTICAL PREPARATION COMPRISING IT
-
Page/Page column 11-14, (2020/07/14)
Substances effective against tuberculosis based on substituted 1,2,4-oxadiazoles of general formula I, where Y = S or CH2 and R = phenyl- or phenyl- substituted in positions 2, 3, 4, and 5 by one or several electron-acceptor groups or electron-donor groups. These compounds can be produced by easy syntheses and are characterized by low toxicity and high efficacy against mycobacteria, including multiresistant strains thereof. The invention also discloses a pharmaceutical preparation containing substituted 1,2,4-oxadiazole of formula I as active substance as well as the use of this substituted 1,2,4-oxadiazole as an antituberculosis drug.
